Pulse Biosciences to Present at the Cantor Global Healthcare Conference
Pulse Biosciences, Inc. (NASDAQ: PLSE), a novel medical therapy company bringing to market its proprietary Nano-Pulse
Stimulation™ platform, announced today that Darrin Uecker, President and Chief Executive Officer, is scheduled to present at
the Cantor Global Healthcare Conference in New York at 4:00 p.m. Eastern Time on Wednesday, October
3rd, 2018.
A live webcast of the presentation will be available through the Investor Relations pages of the Pulse Biosciences website at
http://investors.pulsebiosciences.com/events-calendar and at http://wsw.com/webcast/cantor7/plse/.
Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 90
days.
About Pulse Biosciences
Pulse Biosciences is a novel medical therapy company bringing to market its proprietary Nano-Pulse Stimulation™ (“NPS™”)
platform. NPS is a novel, precise, non-thermal, treatment technology delivering nanosecond duration energy pulses that impact cells
in treated tissue while sparing surrounding acellular tissue. NPS’s unique mechanism of action disrupts the functions of internal
cell structures while maintaining the outer cell membrane initiating a cascade of events within the cell that results in regulated
cell death. In pre-clinical studies, NPS has demonstrated an ability to induce immunogenic cell death in cancer cell lines. The
novel characteristics of NPS’s unique mechanism of action has the potential to significantly benefit patients for multiple medical
applications, including dermatology, the Company’s first planned commercial application, with future potential in other disease
states where an enhanced immune response may be beneficial. More information is available at
www.pulsebiosciences.com.
Investor Relations:
Pulse Biosciences, Inc.
Brian Dow
Sr. Vice President and Chief Financial Officer
IR@pulsebiosciences.com
or
Solebury Trout
Gitanjali Jain Ogawa, 646-378-2949
gogawa@troutgroup.com
or
Media:
Tosk Communications
Nadine D. Tosk, 504-453-8344
nadinepr@gmail.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20181001006032/en/